TPG GP A’s Evolent Health EVH Stock Holding History

TPG GP A’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-268,946	Closed	-$8.15M	–	39
2023 Q2	$8.15M	Sell	268,946 -494,194	-65%	-$16M	0.12%	37
2023 Q1	$24.8M	Buy	+763,140	New	+$24.1M	0.4%	31

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

TPG GP A's EVH Position: Q3 2023 in Review

TPG GP A sold out of Evolent Health (EVH) in Q3 2023, closing a stake of 268,946 shares — an estimated $8.15M sold.

TPG GP A first reported a position in EVH in Q1 2023 and held it in 2 quarters. The position peaked at $24.8M in Q1 2023. 203 funds tracked by Wall St. Rank hold EVH as of Q3 2023.

TPG GP A reported no remaining Evolent Health position as of Q3 2023 after selling out during the quarter.
TPG GP A sold 268,946 Evolent Health shares in Q3 2023, an estimated $8.15M.
TPG GP A first reported a position in Evolent Health in Q1 2023 and held it in 2 quarters.
TPG GP A's Evolent Health position peaked at $24.8M in Q1 2023.
203 funds tracked by Wall St. Rank held Evolent Health as of Q3 2023.

Based on TPG GP A's 13F filing for Q3 2023, filed 14 Nov 2023.